The State Drug Administration approved the listing
Author:Chinese medicine Time:2022.06.29
Recently, the State Drug Administration approved the first -class innovative pharmaceutical (product name: Kenda/Kerendia) reported by Bayer's declaration.This drug is suitable for adult patients with chronic kidney disease related to type 2 diabetes (Estiments of Genomi Filter Overseas Estimation [EGFR]
25 to <75 ml/min/1.73 m2, accompanied by albuminuria), can reduce the risk of continuous decrease in EGFR and end -stage renal disease.
Non -ricone is a non -sterite, selective salt cortex hormone receptor (MR) antagonist.MR is expressed in the kidneys, hearts, and blood vessels, and non -ricone can reduce the inflammation and fibrosis of excessive activation of MR.This drug has provided new treatment options for adult patients related to chronic kidney disease related to type 2 diabetes.
- END -
In order to repel mosquito repellent, the two men were knocked into the hospital on the spot!Emergency reminder: This method is never desirable
The arrival of Mei TianIn addition to the wet sweltering weatherAnother headache i...
Henan Province's epidemic prevention and control headquarters reiterated that the health code is only used for epidemic prevention and control
Henan Province Epidemic Prevention and Control Headquarters requires local governments to strictly implement the Administrative Measures for the Prevention and Control Code of New Crown Crown Pneumon